A detailed history of Planning Alternatives LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Planning Alternatives LTD holds 543 shares of LLY stock, worth $490,171. This represents 0.08% of its overall portfolio holdings.

Number of Shares
543
Previous 447 21.48%
Holding current value
$490,171
Previous $347,000 41.5%
% of portfolio
0.08%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$724.87 - $909.04 $69,587 - $87,267
96 Added 21.48%
543 $491,000
Q1 2024

Apr 17, 2024

BUY
$592.2 - $792.28 $17,173 - $22,976
29 Added 6.94%
447 $347,000
Q4 2023

Jan 23, 2024

BUY
$525.19 - $619.13 $1,575 - $1,857
3 Added 0.72%
418 $243,000
Q3 2023

Oct 17, 2023

BUY
$434.7 - $599.3 $180,400 - $248,709
415 New
415 $222,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $858B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Planning Alternatives LTD Portfolio

Follow Planning Alternatives LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Planning Alternatives LTD , based on Form 13F filings with the SEC.

News

Stay updated on Planning Alternatives LTD with notifications on news.